NCT02280109View on ClinicalTrials.gov

Comparison of Tenofovir Vaginal Gel and Film Formulations

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2015

Conditions
HealthyHIV
Interventions
DRUG

Tenofovir Gel

single dose of 1% tenofovir gel (equivalent to 40 mg in 4ml's of gel)

DRUG

Tenofovir Film

single dose of 1.3% tenofovir film (equivalent to 40 mg)

Trial Locations (1)

21287-5554

Johns Hopkins University School of Medicine Division of Clinical Pharmacology, Baltimore

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

CONRAD

OTHER

NCT02280109 - Comparison of Tenofovir Vaginal Gel and Film Formulations | Biotech Hunter | Biotech Hunter